Drugs / BMP-655/ACS
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT01122498 | Jun 2010 → Apr 2012 | rotator cuff syndrome | Pfizer | Terminated | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | BMP-655/ACS | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01122498 ↗ |
| Modality | Protein / enzyme biologic | “recombinant human bone morphogenetic protein-12 (rhBMP-12)” PMID 28932752 ↗ Sep 2017 |
| Route | Other | “have a single dose of BMP-655/ACS surgically implanted” NCT01122498 ↗ |